CIK 0001620463
- Non-accelerated filer
- Smaller reporting company
LeonaBio, Inc.
Sign in to watch- Ticker
- LONA
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Entity type
- Operating
- EIN
- 453368487
- Phone
- +1 425-620-8501
- Business address
- 18706 NORTH CREEK PARKWAY, SUITE 104, BOTHELL, WA, 98011
- Former names
- Athira Pharma, Inc., M3 Biotechnology, Inc.
- Open-market buys, last 90 days
- $9,919,161,281
- in 1 filing
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$9,919,161,281. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-06-23 | EDELMAN JOSEPH Director | Grant or award · Stock Option (Right to Buy) | +28,000 | 28,000 | ||
| 2026-04-09 | EDELMAN JOSEPH Director | Grant or award · Stock Option (Right to Buy) | +28,000 | 28,000 | ||
| 2025-05-30 | EDELMAN JOSEPH Director | Grant or award · Stock Option (Right to Buy) | +20,900 | 20,900 | ||
| 2024-05-24 | EDELMAN JOSEPH Director | Grant or award · Stock Option (Right to Buy) | +20,900 | 20,900 | ||
| 2023-05-19 | EDELMAN JOSEPH Director | Grant or award · Stock Option (Right to Buy) | +20,900 | 20,900 | ||
| 2022-05-20 | EDELMAN JOSEPH Director | Grant or award · Stock Option (Right to Buy) | +13,871 | 13,871 | ||
| 2021-05-28 | EDELMAN JOSEPH Director | Grant or award · Stock Option (Right to Buy) | +13,871 | 13,871 | ||
| 2020-09-22 | EDELMAN JOSEPH Director | Conversion | +1,644,785 | 2,055,981 | ||
| 2020-09-22 | EDELMAN JOSEPH Director | Purchase | +1,058,824 | $17.00 | $18.0M | 3,114,805 |
| 2020-09-22 | EDELMAN JOSEPH Director | Conversion · Series B Preferred Stock | −1,644,785 | 0 |
Page 1 of 1 · 10 trades